News &amp; Updates

Fall episodes in individuals with atrial fibrillation (AF) may signal poor outcomes, including intracranial haemorrhage and mortality, according to a study.

Falls a red flag for poor outcomes in atrial fibrillation

Cognitive protection greater with intensive vs standard SBP lowering for high-risk individuals

For individuals with increased projected risk of probable dementia or amnestic mild cognitive impairment (MCI) who are prescribed antihypertensive treatment, intensive systolic blood pressure (SBP) lowering confers greater cognitive benefits than standard treatment, according to a secondary analysis of the SPRINT trial.

Cognitive protection greater with intensive vs standard SBP lowering for high-risk individuals

Clevidipine trumps nicardipine for BP control in patients undergoing cardiac surgery

Treatment with clevidipine in patients undergoing cardiac surgery leads to better perioperative blood pressure (BP) control relative to nicardipine, with a slight rise in cost and no significant difference in safety outcomes, a study has found.

Clevidipine trumps nicardipine for BP control in patients undergoing cardiac surgery

GLP1RA added to antidiabetic drugs prevents MACE, HF hospitalization

Adding glucagon-like peptide-1 receptor agonists (GLP1RA) onto metformin, sulfonylurea, or insulin treatment alone or in combination appears to reduce the incidence of major adverse cardiac events (MACE) and heart failure (HF) hospitalization relative to treatment with dipeptidyl peptidase-4 inhibitors (DPP4i), suggests a study.

GLP1RA added to antidiabetic drugs prevents MACE, HF hospitalization

Amiodarone plus apixaban/rivaroxaban ups bleeding-related hospitalizations in older AF patients

Use of amiodarone in older patients with atrial fibrillation (AF) who are being treated with apixaban or rivaroxaban results in a higher risk of bleeding-related hospitalizations compared with the use of flecainide or sotalol, reports a study.

Amiodarone plus apixaban/rivaroxaban ups bleeding-related hospitalizations in older AF patients

Serum ADMA levels linked to circadian BP variability in glaucoma

Serum levels of asymmetric dimethylarginine (ADMA) seem to play a major role in the disturbance of circadian blood pressure (BP) variability in patients with glaucoma, suggests a recent study.

Serum ADMA levels linked to circadian BP variability in glaucoma

27 May 2023

Long-term ACS outcomes similar between TiNO-coated and everolimus-eluting stents